Tempest Therapeutics, Inc. (TPST) earnings
TPST earnings moved a median of -4.93% by the close. Quarterly and annual TPST reports and results, each read against the price at its own news timestamp. Back to the TPST overview →
22 measured TPST earnings events.
Where these TPST earnings landedvs 20 measured TPST earnings reactions
| Middle 50% of TPST earnings reactions | -8.72% to -1.11% |
|---|---|
| Median reaction (to close) | -4.93% |
| Measured reactions | 20 |
Point-in-time · zero look-ahead
Half of the 20 TPST earnings events with a measured close landed between -8.72% and -1.11%; 25% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Tempest Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -2.71% | -9.38% | |
| Tempest Reports Second Quarter 2026 Financial Results and Provides Business Update | Press release | -2.71% | -9.38% | |
| Form 10-Q Tempest Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -6.90% | -8.50% | |
| Tempest Reports First Quarter 2026 Financial Results and Provides Business Update | Press release | -6.90% | -8.50% | |
| Form 10-K Tempest Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -2.37% | -10.06% | |
| Form 10-Q Tempest Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +8.74% | |
| Tempest Reports Third Quarter 2025 Financial Results and Provides Business Update | Press release | +0.00% | +8.74% | |
| Form 10-Q Tempest Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +3.76% | — | |
| Tempest Reports Second Quarter 2025 Financial Results and Provides Business Update | Press release | +3.76% | — | |
| Form 10-Q Tempest Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +1.91% | -1.65% | |
| Tempest Reports First Quarter 2025 Financial Results and Provides Business Update | Press release | +1.91% | -1.65% | |
| Form 10-K/A Tempest Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.00% | -2.98% | |
| Form 10-K Tempest Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +1.27% | -2.27% | |
| Form 10-Q Tempest Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +3.60% | +3.25% | |
| Tempest Reports Third Quarter 2024 Financial Results and Provides Business Update | Press release | +3.60% | +3.25% | |
| Form 10-Q Tempest Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -0.72% | -16.67% | |
| Tempest Reports Second Quarter 2024 Financial Results and Provides Business Update | Press release | -0.72% | -16.67% | |
| Form 10-Q Tempest Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -2.19% | -8.19% | |
| Tempest Reports First Quarter 2024 Financial Results and Provides Business Update | Press release | -2.19% | -8.19% | |
| Form 10-K Tempest Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -0.27% | +0.54% | |
| Form 10-Q Tempest Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +5.63% | -4.93% | |
| Tempest Reports Third Quarter 2023 Financial Results and Provides Business Update | Press release | +5.63% | -4.93% |
Keep exploring
More TPST: analyst actions → · SEC filings → · TPST overview →